Matthew J. Bott

6.4k total citations · 1 hit paper
109 papers, 2.9k citations indexed

About

Matthew J. Bott is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Matthew J. Bott has authored 109 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Pulmonary and Respiratory Medicine, 31 papers in Surgery and 27 papers in Oncology. Recurrent topics in Matthew J. Bott's work include Lung Cancer Diagnosis and Treatment (54 papers), Lung Cancer Treatments and Mutations (37 papers) and Esophageal Cancer Research and Treatment (17 papers). Matthew J. Bott is often cited by papers focused on Lung Cancer Diagnosis and Treatment (54 papers), Lung Cancer Treatments and Mutations (37 papers) and Esophageal Cancer Research and Treatment (17 papers). Matthew J. Bott collaborates with scholars based in United States, Canada and China. Matthew J. Bott's co-authors include Valerie W. Rusch, David R. Jones, Prasad S. Adusumilli, Kay See Tan, Marc Ladanyi, Bernard J. Park, James M. Isbell, Manjit S. Bains, Daniela Molena and James Huang and has published in prestigious journals such as Science, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Matthew J. Bott

99 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma

2011 512 citations Matthew J. Bott, Marie Brevet et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew J. Bott United States	26	2.0k	914	510	503	286	109	2.9k
Takayuki Fukui Japan	30	1.8k 0.9×	870 1.0×	657 1.3×	379 0.8×	181 0.6×	134	2.9k
Jonathan Shamash United Kingdom	30	1.5k 0.7×	981 1.1×	698 1.4×	937 1.9×	425 1.5×	141	3.1k
Khaldoun Almhanna United States	27	1.1k 0.6×	982 1.1×	596 1.2×	1.2k 2.3×	332 1.2×	168	2.5k
Thomas Brodowicz Austria	28	2.0k 1.0×	2.4k 2.6×	585 1.1×	417 0.8×	468 1.6×	126	3.4k
Anthony Brade Canada	31	1.3k 0.7×	699 0.8×	492 1.0×	370 0.7×	180 0.6×	105	2.8k
Daisuke Sakai Japan	22	963 0.5×	1.3k 1.5×	506 1.0×	488 1.0×	304 1.1×	121	2.3k
Conor Steuer United States	27	1.4k 0.7×	1.4k 1.6×	797 1.6×	424 0.8×	512 1.8×	121	2.8k
Ritsuko Komaki United States	32	2.4k 1.2×	1.2k 1.3×	634 1.2×	638 1.3×	512 1.8×	71	3.7k
Yoshihiro Nabeya Japan	27	1.0k 0.5×	886 1.0×	581 1.1×	1.3k 2.6×	270 0.9×	126	2.5k
Victoria Villaflor United States	28	1.2k 0.6×	1.5k 1.6×	600 1.2×	742 1.5×	404 1.4×	132	2.9k

Countries citing papers authored by Matthew J. Bott

Since Specialization

Citations

This map shows the geographic impact of Matthew J. Bott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Bott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Bott more than expected).

Fields of papers citing papers by Matthew J. Bott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J. Bott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Bott. The network helps show where Matthew J. Bott may publish in the future.

Co-authorship network of co-authors of Matthew J. Bott

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. Bott. A scholar is included among the top collaborators of Matthew J. Bott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. Bott. Matthew J. Bott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cooper, A., Michelle S. Ginsberg, Lynette M. Sholl, et al.. (2025). 233P: Chemo-immunotherapy for borderline resectable and unresectable NSCLC. Journal of Thoracic Oncology. 20(3). S148–S148.

Cheng, George Z., et al.. (2025). Shape-sensing robotic-assisted bronchoscopy with integrated mobile cone-beam CT for small nodules: results from the prospective multicentre CONFIRM study. Thorax. 81(3). 267–275.

Caso, Raul, Kay See Tan, Prasad S. Adusumilli, et al.. (2025). Lobectomy improves disease-free survival over sublobar resection for high-risk stage IA non−small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery. 171(2). 510–518.e2. 1 indexed citations

Fick, Cameron N., Brooke Mastrogiacomo, Kay See Tan, et al.. (2024). Clinicopathologic and genomic features associated with brain metastasis after resection of lung adenocarcinoma. JTCVS Open. 22. 458–469.

Kalchiem‐Dekel, Or, Xiaoyue Ma, Paul J. Christos, et al.. (2024). Determinants of radiation exposure during mobile cone‐beam CT‐guided robotic‐assisted bronchoscopy. Respirology. 29(9). 803–814. 6 indexed citations

Tan, Kay See, Prasad S. Adusumilli, Manjit S. Bains, et al.. (2024). Real-world Decision-making Process for Stereotactic Body Radiotherapy Versus Minimally Invasive Surgery in Early-stage Lung Cancer Patients. Annals of Surgery. 1 indexed citations

Tan, Kay See, Joseph Dycoco, Prasad S. Adusumilli, et al.. (2024). A New Functional Threshold for Minimally Invasive Lobectomy. Annals of Surgery. 280(6). 1029–1037. 1 indexed citations

Chu, Ngoc-Quynh, Kay See Tan, Joseph Dycoco, et al.. (2024). Determinants of successful minimally invasive surgery for resectable non–small cell lung cancer after neoadjuvant therapy. Journal of Thoracic and Cardiovascular Surgery. 169(3). 753–762.e6. 2 indexed citations

Husta, Bryan, I‐Hsin Lin, Prasad S. Adusumilli, et al.. (2024). The incremental contribution of mobile cone-beam computed tomography to the tool–lesion relationship during shape-sensing robotic-assisted bronchoscopy. ERJ Open Research. 10(4). 993–2023. 7 indexed citations

10.

Fick, Cameron N., Kay See Tan, Gaetano Rocco, et al.. (2024). High-risk features associated with recurrence in stage I lung adenocarcinoma. Journal of Thoracic and Cardiovascular Surgery. 169(2). 436–444.e6. 10 indexed citations

11.

Resio, Benjamin J., Kay See Tan, Joseph Dycoco, et al.. (2024). Commission on Cancer Standards for Lymph Node Sampling and Oncologic Outcomes After Lung Resection. The Annals of Thoracic Surgery. 119(2). 308–315. 3 indexed citations

12.

Berry, Andrea A., Ashley H. Tjaden, DeAnna Friedman-Klabanoff, et al.. (2023). Persistence of antibody responses to COVID-19 vaccines among participants in the COVID-19 Community Research Partnership. Vaccine X. 15. 100371–100371. 2 indexed citations

13.

Kidane, Biniam, Matthew J. Bott, Jonathan Spicer, et al.. (2023). The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non–small cell lung cancer. Journal of Thoracic and Cardiovascular Surgery. 166(3). 637–654. 24 indexed citations

14.

Schoenfeld, Adam J., Hira Rizvi, Danish Memon, et al.. (2022). Systemic and Oligo-Acquired Resistance to PD-(L)1 Blockade in Lung Cancer. Clinical Cancer Research. 28(17). 3797–3803. 31 indexed citations

15.

Kalchiem‐Dekel, Or, Matthew J. Bott, Jason Beattie, et al.. (2020). Multiplanar 3D fluoroscopy redefines tool–lesion relationship during robotic‐assisted bronchoscopy. Respirology. 26(1). 120–123. 20 indexed citations

16.

Chang, Jason C., Deepu Alex, Matthew J. Bott, et al.. (2019). Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach. Clinical Cancer Research. 25(23). 7113–7125. 67 indexed citations

17.

Sarkaria, Inderpal S., Nabil P. Rizk, Debra A. Goldman, et al.. (2019). Early Quality of Life Outcomes After Robotic-Assisted Minimally Invasive and Open Esophagectomy. The Annals of Thoracic Surgery. 108(3). 920–928. 50 indexed citations

18.

Ruscetti, Marcus, Josef Leibold, Matthew J. Bott, et al.. (2018). NK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. Science. 362(6421). 1416–1422. 268 indexed citations

19.

Barbetta, Arianna, Meier Hsu, Kay See Tan, et al.. (2018). Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery for stage II to III esophageal squamous cell carcinoma. Journal of Thoracic and Cardiovascular Surgery. 155(6). 2710–2721.e3. 38 indexed citations

20.

Brevet, Marie, Shigeki Shimizu, Matthew J. Bott, et al.. (2011). Coactivation of Receptor Tyrosine Kinases in Malignant Mesothelioma as a Rationale for Combination Targeted Therapy. Journal of Thoracic Oncology. 6(5). 864–874. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact